TVTX
Travere Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$55.78-1.64%
Price as of Jul 20, 2026
TVTX ownership
Travere Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
18
Net (3m)
-$5.7M
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jun
Context3-month price +40.8%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 16, 2026 | Baynes Roy D.director | Option | 4,500 | $21.38 |
| Jun 16, 2026 | Coughlin Timothydirector | Sell | 10,000 | $50.07 |
| Jun 16, 2026 | Baynes Roy D.director | Sell | 4,500 | $50.00 |
| Jun 16, 2026 | Coughlin Timothydirector | Option | 10,000 | $26.52 |
| May 21, 2026 | Bruhn Suzanne Louisedirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Orwin John Adirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Coughlin Timothydirector | Grant | 4,000 | — |
| May 21, 2026 | Coughlin Timothydirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Meckler Jeffrey Adirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Bruhn Suzanne Louisedirector | Grant | 4,000 | — |
| May 21, 2026 | Poole Sandradirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Williams Brinkley Ruthdirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Williams Brinkley Ruthdirector | Grant | 4,000 | — |
| May 21, 2026 | Meckler Jeffrey Adirector | Grant | 4,000 | — |
| May 21, 2026 | LYONS GARY Adirector | Grant | 4,000 | — |
| May 21, 2026 | Squarer Rondirector | Grant | 12,000 | $42.26 |
| May 21, 2026 | Baynes Roy D.director | Grant | 12,000 | $42.26 |
| May 21, 2026 | Baynes Roy D.director | Grant | 4,000 | — |
| May 21, 2026 | Orwin John Adirector | Grant | 4,000 | — |
| May 21, 2026 | Squarer Rondirector | Grant | 4,000 | — |
| May 21, 2026 | Poole Sandradirector | Grant | 4,000 | — |
| May 21, 2026 | LYONS GARY Adirector | Grant | 12,000 | $42.26 |
| May 19, 2026 | Coughlin Timothydirector | Sell | 3,250 | $43.49 |
| May 6, 2026 | Inrig Julaofficer: CHIEF MEDICAL OFFICER | Sell | 311 | $43.95 |
| May 6, 2026 | Heerma Peterofficer: CHIEF COMMERCIAL OFFICER | Grant | 8,500 | — |
| May 6, 2026 | REED ELIZABETH Eofficer: Chief Legal Officer and GC | Sell | 20,000 | $45.00 |
| May 6, 2026 | Dube Eric Mdirector, officer: CHIEF EXECUTIVE OFFICER | Option | 22,500 | — |
| May 6, 2026 | REED ELIZABETH Eofficer: Chief Legal Officer and GC | Option | 20,000 | $17.96 |
| May 6, 2026 | Dube Eric Mdirector, officer: CHIEF EXECUTIVE OFFICER | Grant | 45,000 | — |
| May 6, 2026 | Cline Christopher R.officer: CHIEF FINANCIAL OFFICER | Option | 4,250 | — |
Source: TVTX SEC Form 4 filings, latest Jun 16, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their TVTX positions over the last 6 months (SEC Form 13F).
Increased
198
New positions
121
Reduced
187
Sold out
96
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 11.4M | May 18, 2026 |
| FMR LLC | Increased | 11.0M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 10.5M | Feb 17, 2026 |
| FMR LLC | Increased | 9.6M | Feb 17, 2026 |
| BLACKROCK, INC. | Reduced | 7.9M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 7.8M | May 13, 2026 |
| VANGUARD GROUP INC | Reduced | 6.3M | Jan 29, 2026 |
| STATE STREET CORP | Increased | 5.0M | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 4.9M | May 15, 2026 |
| STATE STREET CORP | Increased | 4.8M | Feb 13, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 4.3M | Feb 17, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 4.1M | May 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.0M | May 15, 2026 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | New Position | 3.8M | Feb 17, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 3.8M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.